HUM
US EQUITY
Health Care
Managed Health Care
CIK: 49071
Humana (HUM) Quant Factor Diagnostic & Fair Value Model
Humana (Ticker: HUM) is listed in the Health Care sector (Managed Health Care). Below is its point-in-time financial profile, valuation multiples, and cross-sectional factor diagnostics.
$422.07
+0.26%
Latest Close (2026-10-23)
Market Cap: $120.95M
P/E Ratio: 10.7
Momentum Strength
3M / 12M
+10.74%
1M: +10.98%
12M: +46.69%
Quality (ROE)
Point-in-Time
+25.44%
Trailing Return on Equity
Technical Trend
RSI 14
57.0
SMA50: $397.79
SMA200: $304.85
Valuation Multiplier
Trailing
10.7
Deep Value (Under 15x P/E)
📊
Valuation & Multi-Factor Diagnostic
Deep Value (Under 15x P/E)
HUM trades at an attractive earnings multiple of 10.7x, significantly lower than the broader S&P 500 average.
⚡
Benchmark Factor Strategy
S&P 500 Momentum Alpha Strategy
This strategy applies cross-sectional momentum and quality factor filters across large-cap US equities.
📈 Daily Candlestick & Volume Quant Chart
Interactive lightweight price action & volume breakdown over recent 90 trading days.
均线多头 (MA20/50)
Piotroski F-Score: 9/9 (High Financial Strength)
Official Point-in-Time Financial Filing History
Zero Lookahead Bias: Every financial metric is timestamped at the exact moment officially published to the market.
备案 CIK: 49071 · 10-K 年报 / 10-Q 季报
| Form | Period End | Filing Timestamp (Point-in-Time) | Revenue | Net Income | Operating CF | EPS (Diluted) |
|---|---|---|---|---|---|---|
| 10-Q | 2026-03-31 | 2026-04-29 | $39.65B | $1.19B | $1.25B | $9.83 |
| 10-Q | 2025-12-31 | 2026-04-29 | - | - | - | - |
| 10-Q | 2025-03-31 | 2026-04-29 | $32.11B | $1.24B | $331.00M | $10.30 |
| 10-K | 2025-12-31 | 2026-02-19 | $129.66B | $1.19B | $921.00M | $9.84 |
| 10-K | 2024-12-31 | 2026-02-19 | $117.76B | $1.21B | $2.97B | $9.98 |
| 10-K | 2023-12-31 | 2026-02-19 | $106.37B | $2.49B | $3.98B | $20.00 |
| 10-Q | 2025-09-30 | 2025-11-05 | $32.65B | $195.00M | $2.57B | $1.62 |
| 10-Q | 2024-12-31 | 2025-11-05 | - | - | - | - |
💡 Methodology & Frequently Asked Questions
Key reference details regarding Humana (HUM) valuation multiples, momentum factors, and point-in-time filing conventions.
How should HUM's current valuation multiple be interpreted? ↓
HUM trades at a trailing P/E of 10.7x within the Health Care sector (deep value (under 15x p/e)). Valuation multiples are computed using trailing-twelve-month GAAP earnings against the latest close price.
What are HUM's key momentum and technical factor indicators? ↓
As of the latest close, HUM shows a 1-month return of +10.98%, 3-month return of +10.74%, and 12-month return of +46.69%, with a 14-day RSI of 57.0. Momentum factors reflect short- and intermediate-term price velocity across the equity cross-section.
What is Point-in-Time (PIT) financial data and why does it matter for HUM? ↓
Point-in-Time indexing aligns corporate fundamentals with their official public filing timestamps (Form 10-Q/10-K) rather than accounting period-end dates. This methodology eliminates lookahead bias in historical equity backtests.
How can HUM be incorporated into systematic factor models? ↓
HUM can be evaluated within customized multi-factor models or screened against cross-sectional filters (such as momentum quintiles and return on equity) to analyze historical turnover and risk-adjusted return.